Boston, MA -- (SBWIRE) -- 05/15/2012 -- GlobalData, the industry analysis specialist, has released its new report, "Growth Hormone Deficiency (GHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018". The report is an essential source of information and analysis on the global Growth Hormone Deficiency (GHD) Therapeutics market. The report identifies the key trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Growth Hormone Deficiency (GHD) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents

Scope

The report provides information on the key drivers and challenges of the Growth Hormone Deficiency (GHD) Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Growth Hormone Deficiency (GHD) Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2018.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Growth Hormone Deficiency (GHD) Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Growth Hormone Deficiency (GHD) Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Growth Hormone Deficiency (GHD) Therapeutics market

Reasons to Get this Report

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Growth Hormone Deficiency (GHD) Therapeutics market in future.

Companies Mentioned in this Report: BioPartners GmbH, LG Life Sciences, Ltd., Ipsen S.A., EMD Serono, Inc., Theratechnologies Inc., Eli Lilly and Company, Ambrx, Inc.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market Forecasts to 2017
- Growth Hormone Deficiency (GHD) - Pipeline Analysis and Market Forecasts to 2016
- Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
- Growth Hormone Deficiency - Pipeline Review, H1 2012
- Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Non-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Growth Hormone Deficiency - Pipeline Review, H2 2011
- Muscular Dystrophy (MD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018